NCT03684798

Brief Summary

Mental Contrasting (MC) consists of imaging a desired future and comparing it with obstacles of the present reality in order to increase goal commitment when expectations of success are high. The study aims to investigate the effects of a motivational training (Mental Contrasting with Implementation Interventions; MCII) as a therapeutic add-on to standard treatment in inpatients with Alcohol Use Disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 14, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

August 31, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 26, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2019

Completed
Last Updated

February 5, 2020

Status Verified

February 1, 2020

Enrollment Period

1.6 years

First QC Date

August 31, 2018

Last Update Submit

February 3, 2020

Conditions

Keywords

MCIIAlcohol Use DisorderMotivationMental ContrastingImplementation IntentionsAbstinence

Outcome Measures

Primary Outcomes (2)

  • Number of participants with return to any drinking

    Any drinking as measured by self-report or objective testing

    through study completion at end of treatment, an average of 10 weeks

  • Rate of number of drinking events during treatment

    Drinking Events as measured by self-report

    through study completion at end of treatment, an average of 10 weeks

Secondary Outcomes (3)

  • Number of participants with early treatment termination

    through study completion at end of treatment, an average of 10 weeks

  • Rate of general self-efficacy for abstinence

    through study completion at end of treatment, an average of 10 weeks

  • Rate of goal commitment for abstinence

    through study completion at end of treatment, an average of 10 weeks

Study Arms (2)

Mental Contrasting with Implementation Intentions (MCII)

EXPERIMENTAL

Mental Contrasting with Implementation Intentions (MCII) combines two methods: Mental Contrasting and Implementation Intentions. Mental Contrasting (MC) consists of imaging a desired future and comparing it with obstacles of the present reality (Oettingen, 2000, 2014; Oettingen, Pak, \& Schnetter, 2001) in order to increase goal commitment when expectations of success are high (Gollwitzer, 2014). Implementation Intentions on the other hand specify when, where, and how to strive for a goal in form of an if-then-plan, e.g. "If situation Y is encountered, then I will perform the goal-directed response Z" (Gollwitzer, 2014; Wieber, Thürmer, \& Gollwitzer, 2015).

Other: MCII

Treatment as usual

ACTIVE COMPARATOR

The control group receive a control training, which consists of an exercise from treatment as usual. Thus, patients in the control group are supported in their intention for abstinence and in the reappraisal of risk situations and relapse, while no individual motivational strategies are planned or provided

Other: Treatment as usual

Interventions

MCIIOTHER

In this study, the research staff will work through the MCII approach with the participant as an interactive, face-to-face training. The desired future consists of imaging an abstinent life and comparing it with personally relevant obstacles. Afterwards, the most relevant obstacle will be chosen and an if-then-plan will be formed, that refers to this obstacle.

Mental Contrasting with Implementation Intentions (MCII)

The patients in the control group will receive a 2 x 2 contingency table about the disadvantages and advantages of being abstinent and of drinking. In addition, abstinence intentions of patients in the control group will also be supported and risk situations and relapse events since the last trainings will be reappraised, but without the use of MCII.

Treatment as usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of alcohol use disorder according to DSM 5 (Diagnostic and Statistical Manual)
  • Age: ≥18 years

You may not qualify if:

  • Cognitive deficits that limit the patients' ability to provide informed consent
  • Inability to follow the procedures of the study
  • Acute suicidality
  • Acute psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forel Klinik

Ellikon, Canton of Zurich, 8548, Switzerland

Location

Related Publications (4)

  • Oettingen G. Expectancy effects on behavior depend on self-regulatory thought. Social Cognition 18(2): 101-129, 2000.

    BACKGROUND
  • Oettingen G. Rethinking positive thinking: inside the new science of motivation. New York, NY: Penguin Random House, 2014.

    BACKGROUND
  • Oettingen G, Pak H, Schnetter K. Self-regulation of goal setting: turning free fantasies about the future into binding goals. J Pers Soc Psychol. 2001 May;80(5):736-53.

    PMID: 11374746BACKGROUND
  • Gollwitzer PM. Weakness of the will: Is a quick fix possible? Motivation and Emotion 38: 305-322, 2014.

    BACKGROUND

MeSH Terms

Conditions

Alcoholism

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Susanne Rösner

    Forel Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Research

Study Record Dates

First Submitted

August 31, 2018

First Posted

September 26, 2018

Study Start

August 14, 2017

Primary Completion

March 4, 2019

Study Completion

March 4, 2019

Last Updated

February 5, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations